Mounjaro vs. Tirzepatide & Retatrutide: How to Stop Paying Big Pharma a 60% Brand Tax and Save 50%+ in Europe
Most consumers know the brand name Mounjaro (or Ozempic) but don't realize Mounjaro is simply a trademark for the peptide Tirzepatide — sold in low-capacity disposable pens with a 60% patent markup. Here is the exact milligram math to cut your protocol cost by 50–65% with Synedica 40mg kits, or upgrade to 3rd-generation Retatrutide.
GEO: Spain (Marbella, Barcelona, Madrid), France (Nice, Monaco, Paris), Italy (Milan, Rome), Cyprus & UAE (Dubai)
Scientific Review: Dr. Lukas V. Meyer, Ph.D. (Head of Analytical Chemistry, Synedica Basel R&D)
- Mounjaro = Tirzepatide (100% identical molecule, CAS 2023788-19-2). Ozempic/Wegovy = Semaglutide (CAS 910463-68-2).
- A starter pharmacy Mounjaro 2.5mg KwikPen contains only 10 mg of Tirzepatide total (€380–€550 + €120 doctor visit in the EU).
- One Synedica Tirzepatide 40mg Pen Kit contains 40 mg of >99.45% HPLC pure Tirzepatide (4x 10mg cartridges) = 4 full starter Mounjaro pens, saving 50–65%.
- Want even stronger results? Retatrutide 40mg adds a 3rd receptor (Glucagon GCGR) to Mounjaro's 2 receptors, boosting weight loss from 20.9% to 24.2%.
Direct Expert Answers (Q&A)
Is Mounjaro the same thing as Tirzepatide?
Yes. Mounjaro (and Zepbound) is the commercial trade name owned by Eli Lilly for the active peptide molecule Tirzepatide (CAS 2023788-19-2, molecular weight 4813.45 g/mol). Functionally and chemically, pharmaceutical-grade Tirzepatide (>99.45% RP-HPLC) binds to the exact same GIP and GLP-1 receptors.
How do you save 50% to 65% compared to pharmacy Mounjaro in Europe?
Pharmacy Mounjaro is priced per pen rather than per milligram of active peptide. A starter Mounjaro 2.5mg pen holds only 10 mg total (4 x 2.5mg doses) for €380–€550. A Synedica Tirzepatide 40mg kit supplies 40 mg total (four 10mg cartridges) with reusable 60-click micro-dosing, reducing the price per milligram by over 55% and eliminating recurring €100+ private clinic prescription fees.
What is Retatrutide and why is it considered better than Mounjaro?
Retatrutide (LY3437943) is a 3rd-generation triple agonist targeting GLP-1, GIP, and the Glucagon receptor (GCGR). While Mounjaro (2nd-gen dual agonist) suppresses appetite and improves insulin sensitivity, Retatrutide's third glucagon pathway directly oxidizes visceral and liver fat (thermogenesis), preventing metabolic plateau and achieving 24.2% weight reduction vs 20.9% on Mounjaro.
1. The Brand Illusion: Why Everyone Knows 'Mounjaro' Instead of 'Tirzepatide'
Just as consumers say 'Ibuprofen' vs 'Nurofen' or 'Botulinum toxin' vs 'Botox', pharmaceutical conglomerates spend billions promoting trademarked brand names like Ozempic (active molecule: Semaglutide) and Mounjaro / Zepbound (active molecule: Tirzepatide). In Europe — whether in Marbella, Nice, Milan, Limassol, or Berlin — patients often pay €450 to €800 per month through private aesthetic clinics for Mounjaro without realizing that a starter 2.5mg KwikPen contains a mere 10 milligrams of Tirzepatide in total.
2. How to Beat the Pharma Markup: Cost-per-Milligram Breakdown (Save 50–65%)
Big Pharma locks each dose into a separate non-refillable plastic pen so you cannot micro-titrate economically. Synedica Laboratories Europe solves this by supplying 40 mg of pharmaceutical-grade peptide (four sterile 10mg Type I borosilicate cartridges) with a reusable 60-click anodized pen:
| Parameter | Pharmacy Mounjaro KwikPen (2.5mg / 5mg) | Synedica Tirzepatide 40mg Kit | Synedica Retatrutide 40mg Kit (3rd Gen) |
|---|---|---|---|
| Active Molecule | Tirzepatide (Dual GLP-1 + GIP) | Tirzepatide (Dual GLP-1 + GIP, 99.45% HPLC) | Retatrutide (Triple GLP-1 + GIP + Glucagon, 99.54% HPLC) |
| Total Active Peptide in Box | Only 10 mg (starter pen) or 20 mg (5mg pen) | 40 mg total (4 x 10mg sterile cartridges) | 40 mg total (4 x 10mg sterile cartridges) |
| Duration at 2.5 mg / week | 4 weeks (1 month only) | 16 weeks (4 full months in 1 box!) | 20 weeks at 2.0 mg/wk (5 months in 1 box!) |
| Private Doctor Prescription Fee | Required (€100–€180 per consultation in EU) | Direct Research Supply ( €0 clinic markup ) | Direct Research Supply ( €0 clinic markup ) |
| Net Cost Savings per 1 mg | Baseline (100% Retail Pharma Price + Tax) | Save 55%–65% per milligram | Save 50%+ vs Mounjaro while getting 3rd-Gen potency |
3. Evolution Path: From Ozempic (1G) to Mounjaro (2G) to Retatrutide (3G)
If you are starting a metabolic protocol or hitting a weight-loss plateau on Ozempic or Mounjaro, understanding the three generations of receptor engineering is essential. Generation 1 (Semaglutide / Ozempic) only slows digestion and curbs appetite via GLP-1 (~14.9% weight reduction). Generation 2 (Tirzepatide / Mounjaro) adds GIP to improve insulin sensitivity (~20.9% reduction). Generation 3 (Retatrutide 40mg) adds the Glucagon receptor (GCGR), turning the liver into an active fat-burning furnace, clearing >85% of visceral hepatic fat, maintaining high energy levels, and reaching 24.2% average weight reduction.
4. Step-by-Step Dosing & Transition Schedule (60-Unit Pen Clicks)
Every 10mg Synedica cartridge contains exactly 60 clicks on the dial (1 click = 0.167 mg). Whether you choose Tirzepatide 40mg (exact Mounjaro molecule) or upgrade to Retatrutide 40mg, follow this weekly titration chart:
| Stage & Weeks | Tirzepatide 40mg (Mounjaro Equivalent) | Retatrutide 40mg (Triple Agonist) | Pen Dial Setting (60-Unit Scale) |
|---|---|---|---|
| Weeks 1–4 (Adaptation) | 2.5 mg once weekly | 2.0 mg once weekly | 15 clicks (Tirzepatide) / 12 clicks (Retatrutide) |
| Weeks 5–8 (Core Lipolysis) | 5.0 mg once weekly | 4.0 mg once weekly | 30 clicks (Tirzepatide) / 24 clicks (Retatrutide) |
| Weeks 9–12 (Deep Metabolic Shift) | 7.5 mg once weekly | 6.0–8.0 mg once weekly | 45 clicks (Tirzepatide) / 36–48 clicks (Retatrutide) |
| Week 13+ (Peak Maintenance) | 10.0 mg once weekly | 8.0–10.0 mg once weekly | 60 clicks (Full 10mg cartridge per week) |